Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
CAS Number:
[2423943-37-5]
* VAT and and shipping costs not included. Errors and price changes excepted
